The burgeoning field of precision health just saw a new infusion of capital, with PredictMe closing a $470K seed funding round. The startup is developing technology to analyze epigenetic information coded in DNA, aiming to provide a deeper understanding of how an individual's body has responded to life's challenges.
PredictMe's approach focuses on the intricate biological story reflected in each person's genetic makeup, moving beyond traditional diagnostics to offer insights into the cumulative impact of life experiences. This capital will support their efforts to advance what they describe as the future of precision health.
